GE HealthCare, US36266G1076

GE HealthCare Stock - consensus and analyst snapshot

21.06.2026 - 11:57:14 | ad-hoc-news.de

GE HealthCare sits in the medical technology segment of the S&P 500. On this Sunday, the focus shifts to the latest analyst consensus, rating mix and earnings expectations that frame how the market currently values the stock.

GE HealthCare, US36266G1076
GE HealthCare, US36266G1076

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 11:56 CET. Details in the imprint.

GE HealthCare (US36266G1076) is a major US-based medical technology company whose stock is covered by a broad analyst community. On this Sunday, the focus is on the current analyst consensus and earnings expectations compiled by leading data providers.

Go deeper

All news and data on GE HealthCare stock

Background articles, regulatory filings and market data on GE HealthCare stock are bundled in the dedicated topic area on ad-hoc-news.de.

What the consensus shows

GE HealthCare is followed by a double-digit number of Wall Street analysts who update their models regularly after quarterly results and guidance changes. Their aggregated estimates underpin many institutional valuation models for the stock.

According to major financial data platforms, the consensus currently expects mid-single-digit organic revenue growth over the next year, reflecting stable demand for imaging, diagnostics and patient care solutions. Earnings per share are projected to grow at a similar pace, helped by productivity measures and portfolio mix.

Rating mix and expectations

The rating distribution on GE HealthCare is balanced between Buy and Hold, with a minority of analysts advising Sell, reflecting a generally constructive but not euphoric stance on the name. Target prices cluster in a relatively tight band around the recent trading range.

Against this backdrop, investors often look closely at upcoming catalysts such as the next quarterly report, any changes in full-year guidance and commentary on hospital capital spending trends, as these factors can trigger revisions to forecasts and ratings.

The product behind the stock

GE HealthCare generates most of its revenue from medical imaging systems such as MRI, CT and ultrasound scanners, alongside contrast media and digital health solutions that help hospitals and clinics diagnose and treat patients more efficiently. Service contracts contribute a recurring revenue base.

Where the stock trades today

GE HealthCare shares trade on Nasdaq under the ticker GEHC; the latest available close was $61.59 on 06/18/2026, based on delayed market data.

Key facts on GE HealthCare stock

  • Company: GE HealthCare Technologies Inc.
  • ISIN: US36266G1076
  • WKN: A3D3EJ
  • Ticker: GEHC
  • Venue: Nasdaq
  • Price (as of 06/18/2026, 16:00 ET): 61.59 USD
  • Market cap: 28.02 billion USD (as of 06/18/2026)
  • Sector / Industry: Health Care - Equipment & Supplies
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on GE HealthCare stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US36266G1076 | GE HEALTHCARE | boerse | 69595783 | bgmi